Since little is known about the expression of immune checkpoint receptors on tissue-resident innate lymphocytes, we assessed their expression on trNK cells, ILCs, CD8+ TRM, and CD4+ TRM cells in the distinct tumor locations (Figure 3a, b and Figure S3A). This evidence concerns the gene CD8A and neoplasm.